SYNGENE — Syngene International Share News
0.000.00%
Last trade - 00:00- IN₹167.75bn
- IN₹160.76bn
- IN₹37.39bn
Bristol Myers CEO says India to have largest R&D presence outside US by 2025
India's Biocon falls as Jefferies downgrades to 'underperform'
India's Syngene International extends fall on UBS downgrade, PT cut
Brief: Syngene International Says Assessing Officer Issued Penalty Notice
Brief: Syngene International Concludes Acquisition Of Biologics Manufacturing Facility From Stelis Biopharma
Focus: Indian drug manufacturers benefit from Big Pharma interest beyond China
India's Syngene International down on revenue guidance cut
Brief: India's Syngene International Sept-Quarter Consol Profit Rises
India's Biocon names Peter Bains as group CEO (updated)
India's Syngene International hits record high as Q1 profit jumps
Brief: India's Syngene International June-Quarter Profit Rises
India's Strides Pharma down; Syngene to buy unit in slump sale
India's Syngene up 6% as Q4 profit jumps; stock in overbought zone
Brief: Syngene International Says Growth In Development Services Was Driven Predominantly By Further Orders From Existing Clients
Brief: India's Syngene International March-Quarter Consol Profit Rises
Sun Pharma, Syngene top picks for Jefferies in Indian pharma sector
India's Biocon raises $129 mln from Kotak to fund biosimilars deal
India Stocks: Indian shares set to fall after Adani group calls off $2.5 bln share sale
India's Biocon sells 10% stake in Syngene via open market - filing